Annual Summit 2019: Accelerating Success
Thursday 14th March 2019, London
Pancreatic Cancer UK’s Annual Summit 2019: Accelerating Success is an essential event for anyone with an interest in pancreatic cancer. We welcome health professionals, researchers, policy makers, charities, patients, carers and our supporters to join together to share, learn, network and collaborate.
We know that pancreatic cancer is the toughest cancer to diagnose, treat and survive. 1 in 4 people won’t survive a month, and 3 in 4 won’t survive a year. This is unacceptable and it is up to us, the pancreatic cancer community, to act. It is vital that we accelerate success in the diagnosis, treatment and care of pancreatic cancer.
Accelerating Success will focus on recent significant developments in diagnosis, treatment and research. Through plenary keynotes, panel discussions and breakout sessions, the programme will enable you to share your experiences and learn from the experiences of others, to inspire thinking on how we, as a community, can unite to give people affected by this tough cancer the fair chance of surviving that they deserve.
Professor Steve Pereira, Professor of Hepatology & Gastroenterology, University College London
Dr Hanneke Wilmink, Medical Oncologist, Cancer Centre Amsterdam, Amsterdam UMC
Dr Ganesh Radhakrishna, Consultant Clinical Oncologist, The Christie Foundation NHS Trust
Professor Paula Ghaneh, Professor of Surgery, Department of Clinical and Molecular Medicine, University of Liverpool
Nik Dakin MP, Chair of the All-Party Parliamentary Group on Cancer
Dr Andrew Millar, Consultant Gastroenterologist and Hepatologist North Middlesex University Hospital NHS Trust
Professor Sean Duffy, Clinical Lead, West Yorkshire and Harrogate Cancer Alliance
Delegates will be invited to choose to attend one of the following breakout sessions:
Meeting the needs of pancreatic cancer patients
Pancreatic Cancer UK’s recent patient survey highlighted the need for the provision of greater psychological support and a holistic approach when caring for patients and their families. Information provision and access to specialist dietetic support were also key themes within the results. This session will provide you with an overview of the findings from this national survey and allow the opportunity to discuss the best solutions to meeting these needs with an expert panel.
Clinical trials: developments, expectations and access
Whether designing them, delivering them or participating in them, clinical studies and the new treatments they deliver, benefit us all. But they are not without their challenges; this is especially the case in the context of pancreatic cancer. Join our panel of experts who will discuss current and forthcoming studies and contribute to a discussion on how the pancreatic cancer community can help ensure that clinical trials are more accessible and successful in years ahead.
Optimising the treatment pathway
Optimal treatment pathways are currently a focus of the NHS National Cancer Programme. Using examples of current best practice, and learning from the redesign and implementation of optimal treatment pathways for other cancers, this session will bring together experts in the field to explore the benefits of a holistic and integrated approach to ensure that pancreatic cancer patients eligible for surgery are fit and well to be treated, and have the best chance to live longer.
The Annual Summit 2019: Accelerating Success is not to be missed. Join us to accelerate success in the diagnosis and treatment of pancreatic cancer, and the care of those affected. It’s free to attend, you just need to register to reserve your place.
Future leaders in pancreatic cancer, currently undertaking a PhD directly in or related to the condition, are invited to enter our poster competition. The winner will be awarded £300 and will be invited to present at the Summit. There will also be two runners up who will receive prizes of £100 each and all posters will be displayed at the Summit. The deadline for submission has been extended to Thursday 10th January. Please see full details.